Michel Detheux - Net Worth and Insider Trading

Michel Detheux Net Worth

The estimated net worth of Michel Detheux is at least $241,620 dollars as of 2024-11-13. Michel Detheux is the CEO of ITeos Therapeutics Inc and owns about 26,263 shares of ITeos Therapeutics Inc (ITOS) stock worth over $241,620. Details can be seen in Michel Detheux's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michel Detheux has not made any transactions after 2022-04-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michel Detheux

To

Michel Detheux Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michel Detheux owns 1 companies in total, including ITeos Therapeutics Inc (ITOS) .

Click here to see the complete history of Michel Detheux’s form 4 insider trades.

Insider Ownership Summary of Michel Detheux

Ticker Comapny Transaction Date Type of Owner
ITOS ITeos Therapeutics Inc 2022-04-18 director & Chief Executive Officer

Michel Detheux Latest Holdings Summary

Michel Detheux currently owns a total of 1 stock. Michel Detheux owns 26,263 shares of ITeos Therapeutics Inc (ITOS) as of April 18, 2022, with a value of $241,620.

Latest Holdings of Michel Detheux

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITOS ITeos Therapeutics Inc 2022-04-18 26,263 9.20 241,620

Holding Weightings of Michel Detheux


Michel Detheux Form 4 Trading Tracker

According to the SEC Form 4 filings, Michel Detheux has made a total of 14 transactions in ITeos Therapeutics Inc (ITOS) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in ITeos Therapeutics Inc is the sale of 11,500 shares on April 18, 2022, which brought Michel Detheux around $366,505.

Insider Trading History of Michel Detheux

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michel Detheux Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michel Detheux Ownership Network

Ownership Network List of Michel Detheux

No Data

Ownership Network Relation of Michel Detheux

Insider Network Chart

Michel Detheux Owned Company Details

What does ITeos Therapeutics Inc do?

Who are the key executives at ITeos Therapeutics Inc?

Michel Detheux is the director & Chief Executive Officer of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Aaron I. Davis , and other: See remarks Boxer Capital, Llc .

ITeos Therapeutics Inc (ITOS) Insider Trades Summary

Over the past 18 months, Michel Detheux made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net sale of 350,000 shares made by Boxer Capital, Llc , and a net purchase of 5,000 shares made by Matthew Gall .

In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 350,000 shares of ITeos Therapeutics Inc (ITOS) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 345,000 shares.

ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ITeos Therapeutics Inc Insider Transactions

No Available Data

Michel Detheux Mailing Address

Above is the net worth, insider trading, and ownership report for Michel Detheux. You might contact Michel Detheux via mailing address: C/o Iteos Therapeutics, Inc., 139 Main Street, Cambridge Ma 02142.